Keeping biologicals at low temperatures is an established and effective way of maintaining their potency. This is critical for many types of medicines, vaccines, reagents, and biological samples, which is the reason why laboratories, hospitals, clinics, pharmacies, and more employ medical-grade refrigerators to protect their samples from ambient conditions.
Tubes from cooking oil?
Sponsored PublicationsEppendorf Tubes® BioBased reduce the product-specific carbon footprint and support environmental friendly lab workflow.
Memo Therapeutics and Ono Pharmaceutical enter partnership
Latest NewsAntibody developer Memo Therapeutics AG has snaged a R&D partnership with Ono Pharmaceutical Co. Ltd in the immuno-oncology field.
Reliable medical-grade refrigerators
BackgroundKeeping biologicals at low temperatures is an established and effective way of maintaining their potency. This is critical for many types of medicines, vaccines, reagents, and biological samples, which is the reason why laboratories, hospitals, clinics, pharmacies, and more employ medical-grade refrigerators to protect their samples from ambient conditions.
Healthcare investments in Catalonia at record high
Latest NewsCatalonia’s healthcare start-ups raised €238m in 2021, a new record and 4% up from 2020. Four fifth (83%) of VC came from international investors.
EU Health Union ignoring cardiology
Latest NewsThe European Council has adopted three regulations aimed at improving pandemic preparedness, which together with two other pillars complete the EU Health Union.
Audi and Krajete create CO2 air capture plant
Latest NewsAutomotive company Audi AG and gas fermentation specialist Krajete GmbH are building a highly effective industrial-scale CO2 Direct Air Capturing plant in Linz.
IZB start-up: EpiQMAx
Sponsored PublicationsWith its strategic location on the Martinsried campus, the IZB offers an outstanding opportunity to found a company in the vicinity of science and industry.
Unique solutions in immunology and beyond
Sponsored PublicationsTherapies for autoreactive immune disorders have greatly advanced in the past decades but often have significant side effects. Marinomed Biotech AG strives to improve therapies by increasing the solubility and bioavailability of existing drugs. A proprietary pipeline and Solv4U, a B2B offering for API solubilization, enable the development of clinically meaningful new or improved therapies.
Solar Foods protein from carbon dioxide gets authorisation
Latest NewsFinnish Solar Foods Ltd has got the first ever novel food authorisation for its microbially-produced protein powder Solein.
The pharma lab in times of cell & gene therapies
BackgroundAfter two years online, PharmaLab 2022 returns on site for its 10th edition. Over three days, the congress will offer the opportunity to share the latest experiences with colleagues and to exchange ideas in person.